This results indicate that the AML emerged in the patient upon lineage switch were not derived from T-ALL cells with TCR rearrangement, and suggests that a common NRAS mutated bi-potent leukemia clone with T-ALL and AML potential existed (42). This evidence concerns the gene NRAS and acute myeloid leukemia.